Pharmazeutische Rohstoffe Sex Enhancement Series Flibanserin für Muskelaufbau 167933-07-5
Abstrakt
FALL:167933-07-5
MF:C20H21F3N4O
MW:390.4
EINECS:1806241-263-5
Lagertemperatur. 2-8° C.
Löslichkeit DMSO: soluble10mg/mL, clear
Farbe weiß bis beige
Hazard statements H301-H315-H319-H335
Precautionary statements P261-P301+P310-P305+P351+P338
Hazard Codes T
Risk Statements 25-36/37/38
Sicherheitshinweise 26-45
Beschreibung
Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had “satisfying sexual events”.In those on flibanserin it rose from 2.8 zu 4.5 times a month while women receiving placebo reported also an increase of “satisfying sexual events” from 2.7 zu 3.7 times a month.The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.
The effectiveness of flibanserin was evaluated in three phase 3 clinical trials. Each of the three trials had two co-primary endpoints, one for satisfying sexual events (SSEs) and the other for sexual desire. Each of the 3 trials also had a secondary endpoint that measured distress related to sexual desire.
Anwendung
Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had “satisfying sexual events”. In those on flibanserin it rose from 2.8 zu 4.5 times a month while women receiving placebo reported also an increase of “satisfying sexual events” aus 2.7 zu 3.7 times a month.The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.
Echtheitszertifikat
| Testing Items |
Spezifikationen |
Ergebnisse |
| Characteristics |
An off-white to white powder |
Complied |
| Identifizierung |
Meet the requirements |
Positiv |
| Trocknungsverlust |
≤0,50 % |
0.13% |
| Schwermetalle |
≤20PPM |
<20ppm |
| Reinheit (durch HPLC) |
≥99,0 % |
99.2% |
| Fazit: |
The commodity is complied with the standard of the factory |
1. Hot sales
| Testosteronacetat |
Trenbolonacetat |
T-A001 MGF 2mg |
| Testosteron Cypionat |
Trenbolon Enanthate |
T-A002 PEG MGF 2mg |
| Testosteron Decanoat |
Boldenonacetat |
T-A003 CJC-1295 with DAC 2mg |
| Testosteron Enanthate |
Boldenon undecylenat |
T-A004 CJC-1295withoutDAC 2mg |
| Testosteron Isocaproat |
Boldenon Cypionat |
T-A005 PT-141 10mg |
| Testosteron phenylpropionat |
Boldenonpropionat |
T-A006 MT-1 10mg |
| Testosteronpropionat |
Nandrolon Decanoat |
T-A007 MT-2 10mg |
| Testosteron Undecanoat |
Nandrolonphenylpropionat |
T-A008 GHRP-2 5mg |
| Mesteron |
Nandrolon undecylat |
T-A009 GHRP-6 5mg |
| Testosteron Sustanon 250 |
Nandroloncypionat |
T-A009 GHRP-6 10mg |
| Clostebol-Acetat |
Nandrolonpropionat |
T-A010 Ipamorelin 2mg |
| Methylandrostanolon |
Methyltrienolon |
T-A011 Hexarelin 2mg |
| Methenolon Enanthate |
Drostanolonpropionat |
T-A012 Sermorelin 2mg |
| Methenolonacetat |
Drostanolon Enanthate |
T-A013 Oxytocin 2mg |
| Anadrol |
Stanolone |
T-A014 TB500 2mg |
| Anavar |
Tadalafil |
T-A015 pentadecapeptide BPC 157 2mg |
| Winstrol |
Vardenafil |
T-A016 GH 176-191 2mg |
| Clomifencitrat |
Dianabol |
T-A017 Triptorelin 2mg |
| Toremifencitrat |
Tamoxifencitrat |
T-A018 Tesamorelin 2mg |
| Finasterid |
Hydrochlorid |
T-A020 Gonadorelin 2mg |
| T-A022 Selank 5mg |
T-A021 DSIP 2mg |
T-A020 Gonadorelin 10mg |
Verkaufsleiter